Espinosa de los Monteros FVA, Cortés AB, Martín del Campo PFJ, Espinosa de los Monteros SDF

Language: Spanish
References: 12
Page: 355-357
PDF size: 214.03 Kb.

ABSTRACT

Villoglandular carcinoma of the cervix is a rare but well differentiated form of cervical adenocarcinoma. This neoplasm was described for the first time by Young and Scully in 1989, whereas in 1994 was listed as a histopathologic entity in the World Health Organization’s (WHO) histological typing of cervical cancer. The recognition of this tumor is very important because it has a better prognosis than the more common types of cervical adenocarcinomas. Surgical approach can be conservative because of its favorable prognosis. The age of presentation is younger than the other types of cervical carcinomas. This entity is microscopically characterized by an exophytic proliferation with papillary architecture and null to middle nuclear atypia. We present a case of villoglandular adenocarcinoma of the cervix in a 38 years old women diagnosed in biopsy and who underwent hysterectomy.

REFERENCES

1. Young RH, Scully RE. Villoglandular adenocarcinoma of the uterine cervix. Cancer 1989;63:1773-9.

2. Zaino RJ. Glandular Lesions of the uterine cervix. Mod Pathol 2000;13:261-74.

3. Utsugi K, Shimizu Y, Akiyama F, Umezawa S, Hasumi K. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix. Gynecol Oncol 2004;92:64-70.

4. Jayaram G, Razak A. Villoglandular adenocarcinoma of the cervix, a tumor with bland cytological features: report of a case missed on cytology. Malays J Pathol 2003;25:139-43.

5. Macdonald RD, Kirwan J, Hayat K, Herrington CS, Shawki H. Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis. Ginecol Oncol 2006;100:192-4.

6. Dede M, Deveci GM, Deveci S, Cemal MY, et al. Villoglandular papillary adenocarcinoma of the uterine cervix in a pregnant woman: a case report and review of literature. Exp Med 2004;2002:305-10.

7. Jones MW, Kounelis S, Papadaki H, Bakker A, et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and Human Papillomavirus genotyping. Int J Gynecol Pathol;19:110-7.

8. Alfsen GC, Thoresen SQ, Kristensen GB, Skovlund E, Abeler VM. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioide tumors in all age groups. Cancer. 2000;89:1291-9.

9. Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993;12:1-7.

10. Reed W, Abeler VM, Trope CG. Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?. Tidsskr Nor Laegeforen. 1996;113:2569-71.

11. Datta CK. Well differentiated papillary villoglandular adenocarcinoma of the uterine cervix. W.V. Med J 1997;93:186-8.

12. Bounman A, Oosterhuis GJ, Naudin ten cate L, van Doorn GA. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep’s clothing. Eur J Obstet Gynecol Reproed Biol 1999;87:183-9.